Commercial Access Only

Specimen SS-COM-BTR-0982 // BITTER

Clear Brassica T5-AG-PH

Brassica oleracea var. sabellica

Kale

Clear Brassica SeriesTier 5

Target Trait

95

% reduction

Reported target: 95% bitter reduction

Technical Specifications

Genomic Edits

17

GC Content

(63%)

Construct Length

8,820 bp

Promoter System

Tissue-specific 2A11

Expression System

Agrobacterium-mediated T-DNA

Host Strain

EHA105

Pathway Edits

  • TAS2R38 complete null
  • Glucosinolate complete KO
  • Myrosinase suppression
  • Palatability enhancer integration

Key Interventions

TAS2R38 null allele integrationFull glucosinolate pathway eliminationMyrosinase suppression cassettePalatability enhancer gene integration

Application Domains

PharmaceuticalResearch

Intended Use

Pharmaceutical excipient and nutraceutical formulation — bitterness-masked brassica extracts and active compounds for clinical and supplement applications

Access

Request Commercial Access

This construct is available exclusively to qualified institutions. Submit an inquiry to receive technical documentation and licensing terms.

Contact Us →

No pricing is listed publicly. We respond to all qualified inquiries within 2 business days.

Back to Commercial Catalog